
### [NCIT:C6192](http://purl.obolibrary.org/obo/NCIT_C6192)
**Label:** Inverted Urothelial Papilloma

**Subclasses:** [NCIT:C39859](http://purl.obolibrary.org/obo/NCIT_C39859) (Bladder Inverted Papilloma), [NCIT:C6174](http://purl.obolibrary.org/obo/NCIT_C6174) (Ureter Inverted Papilloma), [NCIT:C6173](http://purl.obolibrary.org/obo/NCIT_C6173) (Urethral Inverted Papilloma), [NCIT:C6187](http://purl.obolibrary.org/obo/NCIT_C6187) (Renal Pelvis Inverted Papilloma), 

**Class expressions from DL-Learner:**

- Thing 54.24%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) 44.40%
- [NCIT:C36767](http://purl.obolibrary.org/obo/NCIT_C36767) (Abnormal Transitional Cell) 44.40%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40177](http://purl.obolibrary.org/obo/NCIT_C40177) (Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential))) 44.40%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40175](http://purl.obolibrary.org/obo/NCIT_C40175) (Uterine Corpus Myxoid Leiomyosarcoma))) 44.40%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40174](http://purl.obolibrary.org/obo/NCIT_C40174) (Uterine Corpus Epithelioid Leiomyosarcoma))) 44.40%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40170](http://purl.obolibrary.org/obo/NCIT_C40170) (Uterine Corpus Diffuse Leiomyomatosis))) 44.40%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40168](http://purl.obolibrary.org/obo/NCIT_C40168) (Uterine Corpus Lipoleiomyoma))) 44.40%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40167](http://purl.obolibrary.org/obo/NCIT_C40167) (Uterine Corpus Bizarre Leiomyoma))) 44.40%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40166](http://purl.obolibrary.org/obo/NCIT_C40166) (Uterine Corpus Myxoid Leiomyoma))) 44.40%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40165](http://purl.obolibrary.org/obo/NCIT_C40165) (Uterine Corpus Apoplectic Leiomyoma))) 44.40%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40164](http://purl.obolibrary.org/obo/NCIT_C40164) (Uterine Corpus Epithelioid Leiomyoma))) 44.40%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40163](http://purl.obolibrary.org/obo/NCIT_C40163) (Uterine Corpus Cellular Leiomyoma))) 44.40%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant))) 44.40%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40161](http://purl.obolibrary.org/obo/NCIT_C40161) (JAZF1-SUZ12 Fusion Protein Expression))) 44.40%


